VEL-101 to Prevent Rejection After Kidney Transplantation

NCT07290777 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Transplantation, Kidney

Interventions

DRUG: Tacrolimus (TAC)
DRUG: VEL-101

Sponsor

Veloxis Pharmaceuticals